Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver.
about
Preoperative portal vein embolization for hepatocellular carcinoma: Consensus and controversyPreoperative selection of patients with colorectal cancer liver metastasis for hepatic resectionPreoperative portal vein embolization in liver cancer: indications, techniques and outcomesStrategies to increase the resectability of hepatocellular carcinomaManagement of "very early" hepatocellular carcinoma on cirrhotic patientsThe role of interventional radiology in the management of hepatocellular carcinomaDevelopment of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panelCombined liver resection and reconstruction of the supra-renal vena cava: the Paul Brousse experience.Hepatic venous pressure gradient in the assessment of portal hypertension before liver resection in patients with cirrhosis.Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection.Liver resection for cancer.Role of angiographic techniques in the preoperative staging and management of gastrointestinal neoplasms.Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival.Sequential transcatheter arterial chemoembolization and portal vein embolization for hepatocellular carcinoma: the university of Tokyo experience.Portal vein embolization: rationale, technique, and current application.Current treatment for liver metastases from colorectal cancer.Improving the quality of liver resection: a systematic review and critical analysis of the available prognostic models.Hepatectomy for hepatocellular carcinoma larger than 10 cm: preoperative risk stratification to prevent futile surgeryRole of portal vein embolization in hepatocellular carcinoma management and its effect on recurrence: a case-control study.Complications of Portal Vein Embolization: Evaluation on Cross-Sectional Imaging.Central Hepatectomy versus Extended Hepatectomy for Malignant Tumors: A Propensity Score Analysis of Postoperative Complications.Acute kidney injury following hepatectomy for hepatocellular carcinoma: incidence, risk factors and prognostic value.Complications after Hepatectomy for Hepatocellular Carcinoma Independently Shorten Survival: A Western, Single-Center Audit.Portal vein embolization before liver resection: a systematic reviewThree-Dimensional Quantitative Evaluation of the Segmental Functional Reserve in the Cirrhotic Liver Using Multi-Modality ImagingKinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnantMargin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapyLimiting factors for liver regeneration after a major hepatic resection for colorectal cancer metastasesLiver failure following partial hepatectomy.Portal vein embolization for hepatocellular carcinoma.Liver surgery in the presence of cirrhosis or steatosis: Is morbidity increased?Volumetric and functional recovery of the remnant liver after major liver resection with prior portal vein embolization : recovery after PVE and liver resection.Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases.Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy.Partial liver volume radioembolization induces hypertrophy in the spared hemiliver and no major signs of portal hypertension.Quality improvement for portal vein embolization.Uses and limitations of portal vein embolization for improving perioperative outcomes in hepatocellular carcinoma.Portal vein embolization: rationale, outcomes, controversies and future directions.Patient selection for surgical management of primary and metastatic liver cancers: current perspectives.Portal vein embolization: what do we know?
P2860
Q26749318-AAB43F3B-9226-4488-965D-C55F1B1E1A89Q26774687-AD0ECEED-AD61-41AA-A14C-BEAEC9B12298Q26774848-1362CA1A-B481-4027-9CFF-215CAE194130Q26795530-A8717683-D4D9-43BC-BB06-38690E54517AQ26864406-3AAA5E11-D89A-4787-9D36-70C6622DDB6BQ26996805-4280429B-7B64-4615-8AFC-33865D11B553Q27014926-8CA199E3-F14D-4F37-ABDB-4325E1A1E0C1Q33247711-C9CA7BB1-F724-4DDE-AA9D-4C6D1346A039Q33400782-A163F2DC-1DE6-49F1-AC32-67212F4D3159Q33604595-230139C3-751B-4C08-9A3A-C9EC192A868DQ34115047-9190DDB8-ED10-4F36-A1EF-9471C9090950Q34277281-AF4155CE-1BBE-4225-AFCC-618E533D3C6DQ34551117-C61798EC-9339-4CFB-AD3C-F972F2576377Q34563749-83AD7338-4E05-4207-A6E7-158B7B7702FDQ34652519-66AE1633-A6A0-4E1C-B22D-9233DB3A7D44Q35047600-FF6BA462-250D-49A4-823B-C357B059BF15Q35099240-37E6E4F9-776B-41D1-9FBE-5F9692816A0CQ35761108-CB7946DD-81DE-42BA-B31F-0E073C7A5947Q36010821-6BBD585F-1462-439E-84E7-0C69220810E0Q36026842-D7708B5A-542E-4318-9513-892F49282A85Q36043789-45006FDD-7E9C-42EE-B5DF-1D4956243045Q36056061-8004C06B-37F8-4066-9F65-9F3156980AD1Q36241693-39422C7F-E842-4F9F-9CEA-748380C36800Q36546055-AF9A52E6-0E45-44E6-B4E5-B147EE611C87Q36663840-BC967C33-B31B-4443-8D6B-C27D06B2F1EBQ36784864-CC716195-E7FA-4EA7-8ADD-0174601F555DQ36844084-F3AC584D-5921-48B3-A94B-C8029D84433DQ37064728-0E3819B2-AD03-47F7-9B38-E1BFA1405D78Q37107288-95F80743-DDC3-4580-B2CC-C18DD6448B03Q37140671-C9EE1627-FC60-4A9E-A6E0-6D4E19F97FDDQ37148509-40A697AF-B3AC-4E8C-9488-787CC6214146Q37261385-504607F3-D0CC-4A8C-B23C-A86E6F9000A2Q37374065-8A73D96A-63B9-43D0-9C0A-86FDA8745981Q37430985-D298EF8A-3A31-4E75-A597-DDBEF99D3923Q37623505-26A0D51E-323E-4C28-A1BD-D20B779BC1DFQ37687163-7D9BB9EE-6353-434F-8AC8-3D563D4444ADQ37759928-9ABC0C6F-F5A9-45AB-B1A7-7B8DDB638A9EQ37777157-BE081494-CDF7-4043-B4E3-14AC2B57861DQ37843561-596E218A-1E6D-4380-B2CF-37BC05CEFB61Q37968916-E9AF188B-FBF6-4A77-B1DB-63B78BBA47E0
P2860
Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Percutaneous portal vein embol ...... ar carcinoma in injured liver.
@ast
Percutaneous portal vein embol ...... ar carcinoma in injured liver.
@en
type
label
Percutaneous portal vein embol ...... ar carcinoma in injured liver.
@ast
Percutaneous portal vein embol ...... ar carcinoma in injured liver.
@en
prefLabel
Percutaneous portal vein embol ...... ar carcinoma in injured liver.
@ast
Percutaneous portal vein embol ...... ar carcinoma in injured liver.
@en
P2093
P2860
P1433
P1476
Percutaneous portal vein embol ...... ar carcinoma in injured liver.
@en
P2093
D Castaing
G M Hargreaves
P2860
P304
P356
10.1097/00000658-200011000-00008
P407
P577
2000-11-01T00:00:00Z